Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 42.57% institutional investors, 1.60% insiders, and 55.83% retail investors. Fmr is the largest institutional shareholder, holding 16.76% of CRNX shares. Vanguard Health Care Inv is the top mutual fund, with 3.31% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 42.57% | 1.60% | 55.83% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.80% | 11.85% | 52.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 15.76M | 16.76% | $572.40M |
| Vanguard group | 9.14M | 9.70% | $425.26M |
| Blackrock funding, inc. /de | 8.48M | 9.01% | $307.95M |
| Farallon capital management | 8.34M | 8.86% | $302.84M |
| Wellington management group llp | 8.16M | 8.67% | $296.27M |
| Blackrock | 6.23M | 8.62% | $279.06M |
| Driehaus capital management | 6.40M | 6.80% | $232.30M |
| Price t rowe associates inc /md/ | 5.36M | 5.69% | $194.51M |
| Janus henderson group | 4.52M | 4.81% | $164.23M |
| Ecor1 capital | 4.29M | 4.56% | $155.74M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 141.00K | 13.64% | $5.87M |
| Ecor1 capital | 4.29M | 6.61% | $155.74M |
| Novo | 1.55M | 4.56% | $56.30M |
| First light asset management | 1.09M | 3.55% | $39.58M |
| Ghost tree capital | 240.00K | 3.37% | $10.75M |
| Bellevue group | 3.28M | 2.84% | $119.13M |
| Semanteon capital management, lp | 5.56K | 2.71% | $202.01K |
| Prosight management, lp | 350.00K | 2.08% | $12.71M |
| Siren | 1.90M | 1.92% | $69.14M |
| Farallon capital management | 8.34M | 1.73% | $302.84M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bellevue group | 3.28M | 2.84% | 3.28M |
| T. rowe price investment management | 1.94M | 0.05% | 1.88M |
| Fmr | 15.76M | 0.03% | 1.47M |
| Farallon capital management | 8.34M | 1.73% | 1.41M |
| Suvretta capital management | 1.04M | 0.97% | 1.04M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -2.34M |
| Paradigm biocapital advisors lp | - | - | -2.21M |
| Vestal point capital, lp | 750.00K | 1.41% | -750.00K |
| Lord, abbett | - | - | -724.63K |
| Eventide asset management | - | - | -609.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Suvretta capital management | 1.04M | 0.97% | 1.04M | $37.91M |
| Vanguard fiduciary trust | 708.47K | 0.01% | 708.47K | $25.73M |
| Marshall wace, llp | 684.11K | 0.02% | 684.11K | $24.85M |
| Braun stacey associates | 324.81K | 0.39% | 324.81K | $11.80M |
| Foresite capital management vi | 212.01K | 1.67% | 212.01K | $7.70M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -8.00 |
| Cubist systematic strategies | -13.00 |
| Physician wealth advisors | -15.00 |
| Northwestern mutual wealth management | -16.00 |
| Bryn mawr trust | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 163 | -34.80% | 40,042,979 | -64.12% | 42 | 0.30% | 108 | -26.53% | 38 | -50.00% |
| Dec 31, 2025 | 204 | -13.92% | 65,989,147 | -38.74% | 70 | 0.53% | 119 | -9.85% | 63 | -11.27% |
| Sep 30, 2025 | 229 | 7.01% | 106,238,854 | 4.14% | 113 | 0.96% | 127 | 0.79% | 71 | 9.23% |
| Jun 30, 2025 | 219 | -2.67% | 104,541,979 | 7.66% | 111 | 1.02% | 129 | 3.20% | 64 | -11.11% |
| Mar 31, 2025 | 227 | -8.84% | 101,882,125 | 2.21% | 109 | 0.71% | 125 | -15.54% | 72 | 9.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 3.49M | 3.31% | 306.20K |
| Vanguard Total Stock Mkt Idx Inv | 3.36M | 3.19% | 11.62K |
| Fidelity OTC | 3.01M | 2.86% | 277.66K |
| Vanguard US Total Market Shares ETF | 2.40M | 2.58% | 2.45K |
| Vanguard Small Cap Index | 2.41M | 2.29% | -8.48K |
| iShares Russell 2000 ETF | 2.30M | 2.18% | 19.36K |
| Polar Capital Biotech S Inc | 2.27M | 2.15% | 2.27M |
| US Small-Cap Growth II Equity Comp | 1.58M | 1.51% | 89.61K |
| T. Rowe Price New Horizons | 1.58M | 1.51% | - |
| Vanguard Small Cap Growth Index Inv | 1.36M | 1.29% | 4.54K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 08, 2026 | Knight Jeff E. | Chief Dev. & Operating Officer | Sell | $3.42M |
| Mar 16, 2026 | Knight Jeff E. | Chief Operating Officer | Sell | $220.80K |
| Mar 16, 2026 | Knight Jeff E. | Chief Operating Officer | Sell | $149.61K |
| Mar 16, 2026 | Betz Stephen F. | Chief Scientific Officer | Sell | $160.18K |
| Mar 16, 2026 | Betz Stephen F. | Chief Scientific Officer | Sell | $236.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 11 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 1 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools